Senzime AB (publ) (STO: SEZI)
Sweden flag Sweden · Delayed Price · Currency is SEK
5.80
+0.13 (2.29%)
Dec 20, 2024, 4:51 PM CET

Senzime AB Company Description

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States.

It offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance to measure the tissue’s opposition to carrying an alternating electrical current.

The company has a strategic connectivity and licensing agreement with Masimo to develop, manufacture, market, and distribute products that can connect to the Masimo Root patient monitoring system and related digital hub for data transmission to hospital electronic patient journals; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system.

Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.

Senzime AB (publ)
Senzime AB logo
Country Sweden
Founded 1999
Industry Medical Devices
Sector Healthcare
Employees 52
CEO Philip Siberg

Contact Details

Address:
Ulls vAeg 41
Uppsala, 756 51
Sweden
Phone 46 18 51 56 40
Website senzime.com

Stock Details

Ticker Symbol SEZI
Exchange Nasdaq Stockholm
Fiscal Year January - December
Reporting Currency SEK
ISIN Number SE0002478776
SIC Code 3845

Key Executives

Name Position
Philip Siberg Chief Executive Officer
Slavoljub Grujicic Chief Financial Officer
Johanna Tulkki Chief Operating Officer
Rianne Lundqvist Waninge Ph.D. Application Scientist
Paula Treutiger Head of Communication and Investor Relations
Anders Selin Executive Vice President of Sales
Michael Noble Vice President Global Marketing
Anders Jacobson Chief Innovation Officer
Catrin Molund Executive Vice President of Business Development
Johanna Faris Head of Q/RA/S